【导读】首批上证 580ETF 、上证 380ETF 及其 ETF 联接基金获批 中国基金报记者 李树超 又有重要 ETF 产品获批！ 7 月 11 日，华夏、易方达基金首批上报的上证 580ETF 、上证 380ETF 及其 ETF 联接基 金获批。 受访机构表示，上证 380 指数聚焦中盘新蓝筹，上证 580 指数捕捉小盘成长机遇，两大指 数填补了上证旗舰宽基指数体系在中小市值公司表征上的空白，投资者布局上证旗舰宽基指 数又添新选择。 又有 ETF 创新产品获批 | 指数回报与风险特征 | | | (最新交易日:2025/07/10) ② | | | | | | | 年化 累计 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 最新 | | 本周 | 本月 | 近一月 | 近三月 | 近一年 | 近三年 | 近五年 | 近十年 | 基日以来 | | 0.41% | | 1.60% | 1.48% | 4.06% | 12.84% | 39.02% | -0.43% | 2.00% | 7.60% | 7.60% ...

"牛市旗手"再次爆发，A股顶流券商ETF（512000）场内价格一度飙升4.35%，刷新年内新高，收涨 2.36%，全天成交额19.52亿元，环比放量139.8%。 | 分时 多日 · 综合屏 F9 航复权 超级盈加 面式 工具 @ (2) > | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 512000.SHI券商ETF] 2025/02/14 收1.083 幅0.19%(0.002) 开1.078 高压 MAS 1.080T MA10 1.067T MA20 1.0541 MA60 1. 1 MA120 1.0291 MA2 7 . | | 1.130 +0.026 +2.36% | | | 512000 | | | 1.160 | | SSE CNY 15:00:18 闭市 | | | 25 / 10 / | | | 1.152- | 净值走势 | 学宝中证全指证券ETF | | ਦੇ ਦੇ | 0.89% 120日 | 10.147 | | | 曼比 | 3.03% 委常 | 5901 | 5日 | 4.44% 250日 | 50 ...

| 重合持股 (2025-03-31) | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 股票名称 | 持仓市值(元) | 持仓数量 | 相对上期增减 | 占股票市值比 | 占基金净值比 | 占流通股本比 | | 成都银行 | 416,833,623.09 | 24,248,611 | 16.17% | 2.82%T | 2.81%1 | 0.57% | | 雅戈尔 | 378,143,123.B8 | 45.857.884 | 9.85% | 2.56%- | 2.54% | 1.01% | | 示机器行 | 376.409.462.40 | 17,426,364 | 118 | 2.55% | 2.53% | 0.08% | | 沪农商行 | 375.117,354.00 | 44,978,100 | 9.53% | 2.54% | 2.52% | 0.48% | | 南钢股份 1 | 369,174,793.00 | 80.081.300 | 9.53% | 2.50% | 2.48%4 | 1.30% | | 四川路桥 | 368, ...

Core Insights - The recent issuance of the "Measures to Support the High-Quality Development of Innovative Drugs" by the National Medical Insurance Administration and the National Health Commission marks a significant breakthrough in China's innovative drug payment system, focusing on a dual-track payment model of "medical insurance + commercial insurance," research and development support, and expedited drug availability [1][1][1] Industry Summary - The new policy establishes a "commercial insurance innovative drug catalog," promoting collaboration between medical insurance and commercial insurance to provide multi-layered payment guarantees for high-value new drugs, addressing accessibility bottlenecks for innovative drugs [1][1] - The policy encourages insurance capital to directly invest in innovative drug research and development, fostering patient capital to accelerate the transformation of research pipelines [1][1] - The biopharmaceutical industry is showing signs of a turning point, with nearly 40 innovative drugs approved in the first half of 2025, leading to a surge in demand for upstream life science services, alongside a trend of domestic substitution catalyzed by tariff barriers [1][1] - Major industry players are accelerating mergers and acquisitions, enhancing the overall sector's prosperity, with companies like King’s Ray Biotech and Nanwei Technology benefiting from the innovative drug business development boom [1][1] - Data indicates that commercial health insurance premium income will reach 977.3 billion yuan in 2024, forming a collaborative foundation with medical insurance funds, while patient five-year survival rates have improved to 43.7%, validating the clinical value of innovative drugs [1][1] Company Summary - The E Fund Medical ETF Linked Fund (Class A: 001344; Class C: 007883) aligns well with this trend, closely tracking the CSI Medical and Health Index, covering core areas such as innovative drugs, biotechnology, and medical devices, demonstrating both industry representation and balance [1][1] - The fund features efficient and transparent operations, primarily tracking the E Fund CSI 300 Medical ETF (512010) with an annual management fee rate of only 0.5%, making it accessible for ordinary investors starting with an investment of 10 yuan [1][1] - The underlying ETF has ample liquidity, ensuring smooth capital inflows and outflows, and as of July 10, 2025, the medical index valuation is reasonable, with a price-to-earnings ratio of approximately 29 times, showing steady returns driven by favorable policies [1][1]

Core Insights - The rare earth industry is experiencing a significant price increase for related transactions, with two leading companies announcing a price hike for Q3 2025, leading to a bullish market sentiment and increased trading activity in the rare earth sector [1] - The rare earth ETF (516780) saw a record daily trading volume of 207 million yuan on July 10, 2025, indicating strong investor interest [1] - A recent report from Guotou Securities highlights the rigid supply of rare earths and increasing demand, particularly from sectors like electric vehicles and wind power, which is expected to drive prices higher [1][2] Industry Performance - The price of rare earth concentrates has been on a rising trend for four consecutive quarters since Q4 2024, reflecting improved industry conditions [1] - The report notes that the export restrictions on certain rare earth elements have caused significant price surges in Europe, with price differentials exceeding three times between domestic and international markets [1] - The rare earth ETF tracks the performance of companies involved in mining, processing, trading, and application of rare earths, with top constituents including Northern Rare Earth, China Rare Earth, and China Aluminum [1] Market Outlook - The rare earth sector is poised for multiple catalysts due to the recovery in industry conditions and potential supply chain optimizations [2] - Investors are encouraged to consider the rare earth ETF (516780) and its associated funds as a way to capitalize on the opportunities presented by this strategic resource [2]

中证网讯近期，光伏行业在政策面利好叠加行业自律预期推动，板块情绪回暖，同时"反内卷"驱动下， 多晶硅和工业硅价格快速反弹，上证180指数成分股中的大全能源、通威股份（600438）、天合光能以 及合盛硅业（603260）等光伏产业龙头企业涨幅扩大，带动指数快速上行。 上证180指数是兼顾科技成长和红利资产的沪市核心宽基指数，相比沪深300和中证A500等主流宽基产 品，目前上证180指数有着更低的估值水平和更高的股息率。此外，上证180指数中以科创板为代表的科 技板块权重更高。当前市场呈现明显的哑铃特征，分红和成长两个风格表现较优，上证180指数恰是兼 顾高分红资产和成长板块，是当前市场环境下优质的宽基选择。投资者可持续关注上证180指数的配置 价值，通过兴业上证180ETF(530680)及其联接基金(A类：023148，C类：023149)，布局A股市场的中长 期投资机会。(万宇) 关税问题逐步落地后，兴业基金研判认为，海外风险对中国市场的影响将进一步减小，三季度A股市场 将有一段以国内因素和企业业绩主导的相对平稳的时间窗口。目前市场对三季度中报行情乐观，因此投 资者可根据自身投资需求稳步加大对A股市场的 ...

（文章来源：每日经济新闻） 没有股票账户的投资者可以通过矿业ETF的联接基金（018168）把握有色矿业板块的投资机会。 注：如提及个股仅供参考，不代表投资建议。指数/基金短期涨跌幅及历史表现仅供分析参考，不预示 未来表现。市场观点随市场环境变化而变动，不构成任何投资建议或承诺。文中提及指数仅供参考，不 构成任何投资建议，也不构成对基金业绩的预测和保证。如需购买相关基金产品，请选择与风险等级相 匹配的产品。基金有风险，投资需谨慎。 有色矿业盘中拉升，矿业ETF（561330）、有色60ETF（159881）均涨超2.5%。 东兴证券表示，本次"反内卷"政策旨在防止行业同质化恶性竞争且强调破除地方保护，利用市场机制及 行业自律机制优化升级产能，并实现行业高端化及绿色化转型。从库存观察，钢铁库存已出现持续性去 化且呈现被动式调整特征。从盈利能力观察，2021~2024年，受房地产市场下行影响，行业ROE和ROA 已再度降至历史低位。考虑到"反内卷"政策出台或在短期内推动市场交易情绪修复并刺激长期低迷的库 存周期抬头，促发阶段性的风险情绪交易机会并优化及强化行业的供需状态及利润质量，我们认为钢铁 行业产能集中度的攀 ...

截至2025年7月11日 10:39，中证稀有金属主题指数强势上涨2.41%，成分股三川智慧20cm涨停，北方稀土上涨9.85%，中科磁业上涨8.22%，盛和资源、中国 稀土等个股跟涨。稀有金属ETF(562800)上涨2.35%。 数据显示，截至2025年6月30日，中证稀有金属主题指数前十大权重股分别为盐湖股份、北方稀土、洛阳钼业、华友钴业、赣锋锂业、天齐锂业、中国稀 土、西部超导、中矿资源、厦门钨业，前十大权重股合计占比54.07%。 流动性方面，稀有金属ETF盘中换手3.5%，成交3072.86万元。拉长时间看，截至7月10日，稀有金属ETF近1周日均成交3771.17万元，居可比基金第一。 规模方面，稀有金属ETF近1年规模增长1682.40万元，新增规模位居可比基金第一。数据显示，杠杆资金持续布局中。稀有金属ETF最新融资买入额达 207.87万元，最新融资余额达2128.11万元。 截至7月10日，稀有金属ETF近1年净值上涨30.36%。从收益能力看，截至2025年7月10日，稀有金属ETF自成立以来，最高单月回报为24.02%，最长连涨月 数为3个月，最长连涨涨幅为14.06%，上涨月份平均 ...

| 设置 画线 | | 除权 窗 区 信息 删自选 ● | | 黄金ETF基金 159937 | | 5日 | | --- | --- | --- | --- | --- | --- | --- | | 0: 6.262 MA60: 6.093 | | | | | | 601 | | | 8.010 | 8.140 | | 7. 364 +0.006 +0.082% | | | | | | | 载 | +0.71% | 189 | | | | | 7.812 | 5 | 7.368 | 1783 | | | | | 7.561 | 4 | 7.367 | 2620 | | | | | | 3 | 7.366 | 2028 | | | | | | 益 2 | 7.365 | 6528 | र्स | | | | 7.274 | | | 中则 | | | | | | | 7.364 | 246 | | | | | | | | 最/ | | | | | 6.982 | | 7.363 | 6156 现 | | | | | | 2 नि | 7.362 | 2366 中师 | | | | | | 3 | 7.361 ...

开源证券表示，6月上交所新开户人数同比高增，交易量活跃、债市和股市向好、海外业务充分受益于 港股市场高景气，预计上市券商中报业绩延续一季度以来的同比高增，关注后续业绩预告、稳定币等主 题催化，继续看好券商板块机会。 有行情，买券商！公开资料显示，券商ETF（512000）及其联接基金（A类 006098；C类007531）被动 跟踪中证全指证券公司指数，一键囊括49只上市券商股，其中近6成仓位集中于十大龙头券商，"大资 管"+"大投行"龙头齐聚；另外4成仓位兼顾中小券商的业绩高弹性，吸收了中小券商阶段性高爆发特 点，是集中布局头部券商、同时兼顾中小券商的高效率投资工具。 提醒：近期市场波动可能较大，短期涨跌幅不预示未来表现。请投资者务必根据自身的资金状况和风险 承受能力理性投资，高度注意仓位和风险管理。 数据来源：沪深交易所、Wind、华宝基金等。 A股顶流券商ETF（512000）高开高走，场内价格现涨2．8%，实时成交额近6亿元，交投活跃。 | 分时 7 | | | 19 品前公后 壁机 九州 图特 工月 (0) (2) > | | | | | | | | 券商ETF (1 | | ਗਾ | | --- ...